Indian Journal of Pharmacy Practice
Volume 12, Issue 3
2019 · pp. 154–214 · 12 articles
- Volume
- 12
- Issue
- 3
- Published
- 2019
- Pages
- 154–214
- Articles
- 12
- Sections
- 4
- ISSN
- Online - 0974-8326
- Journal
- IJOPP
In this issue
Editorial
- Forum Article
Rabia Hussain, Mohamed Azmi Hassali, Isha Patel
pp. 154–155 · DOI: 10.5530/ijopp.12.3.34 · 2019
The notorious Nipah virus is again in action in India and in May 2018 it has took 19 lives in Indian states named Kerala and Karnataka.1 A total of 19 cases have been reported to be under treatment for the virus.1 The si…
Review Article
- Review
Purnima Ashok, Blessy Maria Thomas
pp. 156–160 · DOI: 10.5530/ijopp.12.3.35 · 2019
G6PD Deficiency is considered as the most frequently seen enzymopathy affecting the erythrocytes. It has high prevalence rates in the regions of tropical Africa, the Middle East, tropical and subtropical Asia. Severe G6P…
Research Article
- Article
Shiv Kumar, G. Madhuri, Anju Wilson, Tigi S George
pp. 161–166 · DOI: 10.5530/ijopp.12.3.36 · 2019
Background:Chronic obstructive pulmonary disease, a common preventable and treatable disease has been a major public health problem in this century and is one of the leading causes of morbidity and mortality in the indus…
- Article
Kamal Saini, Rajveer Singh, Divyani Agrawal
pp. 167–170 · DOI: 10.5530/ijopp.12.3.37 · 2019
Background:Pregnancy is the most vulnerable condition prone for anemia (most commonly iron deficiency anemia). Hence requires drug therapy for iron store replenishment. Comparing the safety between ferrous carboxymaltose…
- Article
Praisy Johnson, Sasubilli Lavanya, Jisin Abraham, Githa Kishore
pp. 171–175 · DOI: 10.5530/ijopp.12.3.38 · 2019
Background: Globally the quality of life (QOL) among the elderly is deteriorating. Therefore, it should be considered as an important aspect to improve their health and wellbeing. Objectives:To assess the quality of life…
- Article
Meshwa Soni, Rutul Patel, Komal Patel, Janki Patel, Shrikalp Deshpande
pp. 176–187 · DOI: 10.5530/ijopp.12.3.39 · 2019
Background:Antibacterials are the most imperative weapons in our hands, accounting for the majority of ambulatory care prescriptions. Irrational use of antibiotics in developing countries like India have led to emergence…
- Article
Hanan Mohammed Al Yousef, Syed Wajid, Ibrahim Sales
pp. 188–193 · DOI: 10.5530/ijopp.12.3.40 · 2019
Background and Objectives:Herbal products are widely used in many countries in various forms including roots, leaves, barks seeds and so many, for inhibiting and treating Number of minor and major disorders. The purpose …
Case Report
- Article
Milovan Stojanović, Sonja Stojanović, Jovan Nedović, Slađana Božilov
pp. 194–197 · DOI: 10.5530/ijopp.12.3.41 · 2019
Bakers cyst is synovial cyst that is located in popliteal fossa. Rupture of meniscus and inflammatory diseases of synovial joints are the most common cause of Bakers cyst. Cyst diagnosis is based on a clinical picture, t…
- Article
Mahek Mistry, Vikas R. Chandrakar, Hemraj Singh Rajput
pp. 198–201 · DOI: 10.5530/ijopp.12.3.42 · 2019
Escitalopram is a selective serotonin reuptake inhibitor (SSRI) and S-enantiomer of racemic escitalopram, enhances serotonergic activity in the central nervous system (CNS). It is indicated for the Major depressive disor…
- Article
Anisha Thomas, Raima Roy, Akhila S Arjun
pp. 202–204 · DOI: 10.5530/ijopp.12.3.43 · 2019
Cushing’s syndrome is a rare endocrine disorder that comprises a large group of signs and symptoms resulting from chronic exposure to excess cortisol, a hormone that adrenal gland produces and corticosteroids. Most cases…
- Article
Satyavardhan Rao Nittu, Akhila D
pp. 205–208 · DOI: 10.5530/ijopp.12.3.44 · 2019
Consequences of inappropriate medication use have been the subject of professional, public and congressional discourse from ages. The pharmacy profession has accepted responsibility for providing patient education and co…
- Article
Swati Jadhav, Ravindra Ghooi
pp. 209–214 · DOI: 10.5530/ijopp.12.3.45 · 2019
The government notified the New Drugs and Clinical Trial Rules on 19th March 2019, to replace Part XA and Schedule Y of the Drugs and Cosmetics Rules 1945. Many new desirable changes have been made and these will help cl…

